GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (OCSE:ALK B) » Definitions » Other Long Term Assets

Alk-Abello AS (OCSE:ALK B) Other Long Term Assets : kr787 Mil (As of Mar. 2025)


View and export this data going back to 2005. Start your Free Trial

What is Alk-Abello AS Other Long Term Assets?

Alk-Abello AS's other long-term assets for the quarter that ended in Mar. 2025 was kr787 Mil.

Alk-Abello AS's quarterly other long-term assets declined from Sep. 2024 (kr896 Mil) to Dec. 2024 (kr813 Mil) but then stayed the same from Dec. 2024 (kr813 Mil) to Mar. 2025 (kr787 Mil).

Alk-Abello AS's annual other long-term assets declined from Dec. 2022 (kr1,003 Mil) to Dec. 2023 (kr906 Mil) and declined from Dec. 2023 (kr906 Mil) to Dec. 2024 (kr813 Mil).

Alk-Abello AS Other Long Term Assets Historical Data

The historical data trend for Alk-Abello AS's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello AS Other Long Term Assets Chart

Alk-Abello AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 895.00 991.00 1,003.00 906.00 813.00

Alk-Abello AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 899.00 902.00 896.00 813.00 787.00

Alk-Abello AS Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Alk-Abello AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (OCSE:ALK B) » Definitions » Other Long Term Assets
Comparable Companies
OCSE:ZEAL OCSE:BAVA OCSE:GUBRA OCSE:GMAB OCSE:PEG OCSE:STRAP VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX INSM HKSE:01801 SMMT RPRX
Traded in Other Exchanges
ALKBc:UK 0OIR:UK 4AJ0:Germany
Address
Boge Alle 6-8, Horsholm, DNK, DK-2970
Website
https://www.alk.net
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.

Alk-Abello AS Headlines

No Headlines